期刊文献+

羟基红花黄色素A抑制新生血管形成的机制研究 被引量:85

Research on the Mechanism of Hydroxysafflor Yellow A in Inhibiting Angiogenesis
原文传递
导出
摘要 目的 从中药中寻找新的血管生成抑制剂 ,并探讨其抑制新生血管生成的作用机理。方法 从红花中提取分离羟基红花黄色素A ,利用鸡胚尿囊膜 (CAM)实验观察羟基红花黄色素A对新生血管的抑制作用 ,并通过RT PCR实验 ,观察羟基红花黄色素A对CAM组织中碱性成纤维细胞生长因子 (bFGF)、血管内皮细胞生长因子 (VEGF)及其受体 (VEGF R) (flt 1)mRNA表达的影响。结果 提取出的羟基红花黄色素A纯度达到了 98 9% ,浓度为 0 5 9g L的羟基红花黄色素A能使CAM血管数明显变细减少 (P <0 0 1)并能显著抑制CAM组织中bFGF、VEGF及VEGF R(flt 1)的mRNA表达 (P <0 0 5 )。结论 通过本实验我们首次得出羟基红花黄色素A能显著抑制CAM新生血管生成 ,其作用机制之一是通过抑制bFGF、VEGF及VEGF R(flt 1)的mRNA表达来实现的 ,提示羟基红花黄色素A可能是一很有潜力的血管生成抑制剂。 Objective To find new angiogenic inhibitors from TCM drugs and investigate their mechanisms of inhibiting angiogenesis.Methods Hydroxysafflor yellow A was separated from the dried flowers of Carthamus tinctorius; the chick embryo chorioallantoic membrane (CAM) test was carried out to observe the effect of hydroxysafflor yellow A on angiogenesis; RT-PCR was used to observe the effects of hydroxysafflor yellow A on the mRNA expressions of bFGF, VEGF and VEGF-F(flt-1) in the CAM.Results Hydroxysafflor yellow A extracted from the dried flowers of Carthamus tinctorius was of purity of 98.%; hydroxysafflor yellow A could markedly reduce the number of CAM vessels when it was at the concentration of 0.59 g/L (P<0.01), and remarkably inhibit the mRNA expressions of bFGF, VEGF and VEGF-F(flt-1) in the CAM (P<0.05). Conclusion It is the first time when hydroxysafflor yellow A has been discovered to have the effects of markedly inhibiting angiogenesis in CAM, one of the mechanisms of which may be its inhibiting the mRNA expressions of bFGF, VEGF and VEGF-F(flt-1). The results of the experiment suggest that hydroxysafflor yellow A may become a potential angiogenic inhibitor.
出处 《北京中医药大学学报》 CAS CSCD 北大核心 2004年第3期25-29,共5页 Journal of Beijing University of Traditional Chinese Medicine
基金 高等学校博士学科点专项科研基金资助项目 (No .2 0 0 0 2 7) 国家中医药管理局留学回国人员资助项目 (B类 )
关键词 羟基红花黄色素A 血管内皮细胞生长因子 碱性成纤维细胞生长因子 鸡胚尿囊膜 血管生成抑制剂 Hydroxysafflor Yellow A VEGF bFGF Chick Embryo Chorioallantoic Membrane Angiogenic Inhibitor
  • 相关文献

参考文献9

  • 1Cao Y,O'Reilly MS,Marshall B,et al. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. J Clin Invest,1998,101(5):1055-1063
  • 2Nelson NJ. Angiogenesis research is on fast forward. J Natl Cancer Inst,1999,91(10):820-822
  • 3Mukhopadhyay D,Nagy JA, Manseau EJ,et al. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium. Cancer Res,1998,58(6): 1278-1284
  • 4Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 1996,86:353
  • 5Presta LG,Chen H,O'Connor SJ,et al. Humanization of anti-vascular endothelial growth factor monoclonal antibody for therapy of solid tumors and other disorders. Cancer Res,1997,57(20):4593-4599
  • 6Belotti D, Paganoni P, Giavazzi R. MMP inhibitors:experimental and clinical studies. Int J Biol Markes, 1999, 14(4):232-238
  • 7Small EJ,Meyer M,Marshall ME,et al. Suramin therapy for patients with symptomatic hormone refractory prostate cancer:results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone. J.Clin Oncol, 2000,18(7): 14
  • 8金鸣,高子淳,李金荣,臧宝霞,吴伟.大孔树脂柱色谱法制备红花黄色素和羟基红花黄色素A[J].中草药,2004,35(1):25-28. 被引量:57
  • 9张前 牛欣 解华.中药通光藤抑制新生血管生成的实验研究[J].中国医药学报,2002,17:180-182.

二级参考文献2

共引文献57

同被引文献1077

引证文献85

二级引证文献1113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部